In-silico identification of peroxisome proliferator-activated receptor (PPAR)α/γ agonists from Ligand Expo Components database

References

• Ahmad, A., Ahmad, A., Sudhakar, R., Varshney, H., Subbarao, N., Ansari, S., Rauf, A., & Khan, A. U. (2017). Designing, synthesis, and antimicrobial action of oxazoline and thiazoline derivatives of fatty acid esters. Journal of Biomolecular Structure & Dynamics, 35(15), 3412–3431. doi:10.1080/07391102.2016.1255260
   PubMed Web of Science ®Google Scholar
• Ahmed, R., Jain, S. K., & Shukla, P. K. (2013). in-silico characterization of beta-(1, 3)-endoglucanase (ENGL1) from Aspergillus fumigatus by homology modeling and docking studies. Bioinformation, 9(16), 802–807. doi:10.6026/97320630009802
   PubMedGoogle Scholar
• Aziz, T. A., Hussain, S. A., Mahwi, T. O., Ahmed, Z. A., Rahman, H. S., & Rasedee, A. (2018). The efficacy and safety of Ginkgo biloba extract as an adjuvant in type 2 diabetes mellitus patients ineffectively managed with metformin: A double-blind, randomized, placebo-controlled trial. Drug Design, Development and Therapy, 12, 735–742.
   PubMed Web of Science ®Google Scholar
• Baby, S. T., Sharma, S., Enaganti, S., & Cherian, P. R. (2016). Molecular docking and pharmacophore studies of heterocyclic compounds as Heat shock protein 90 (Hsp90) inhibitors. Bioinformation, 12(3), 149–155. doi:10.6026/97320630012149
   PubMed Web of Science ®Google Scholar
• Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018). IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice, 138, 271–281. doi:10.1016/j.diabres.2018.02.023
   PubMed Web of Science ®Google Scholar
• Cronet, P., Petersen, J. F., Folmer, R., Blomberg, N., Sjöblom, K., Karlsson, U., Lindstedt, E. L., & Bamberg, K. (2001). Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family. Structure ( Structure), 9(8), 699–706. doi:10.1016/S0969-2126(01)00634-7
   PubMed Web of Science ®Google Scholar
• Engwa, G. A., Nwalo, F. N., Chiezey, V. O., Unachukwu, M. N., Ojo, O. O., & Ubi, B. E. (2018). Assessment of the Pro12Ala polymorphism in the PPAR-gamma2 gene among type 2 diabetes patients in a Nigerian population. J Clin Med, 7(4), 69.
   Web of Science ®Google Scholar
• Farshadpour, F., Taherkhani, R., Ravanbod, M. R., & Eghbali, S. S. (2018). Prevalence and genotype distribution of hepatitis C virus infection among patients with type 2 diabetes mellitus. Medical Principles and Practice : Practice, 27(4), 308–316. doi:10.1159/000488985
   PubMed Web of Science ®Google Scholar
• Gholami, S., Bordbar, A. K., & Lohrasebi, A. (2017). Identifying binding modes of two synthetic derivatives of adrenalin to the alpha2C-adrenoceptor by using molecular modeling; insights into the alpha2C-adrenoceptor activation. Biophysical Chemistry, 223, 17–24. doi:10.1016/j.bpc.2017.01.005
   PubMed Web of Science ®Google Scholar
• Hasan, M. A., Mazumder, M. H., Chowdhury, A. S., Datta, A., & Khan, M. A. (2015). Molecular-docking study of malaria drug target enzyme transketolase in Plasmodium falciparum 3D7 portends the novel approach to its treatment. Source Code for Biology and Medicine, 10, 7.
   PubMed Web of Science ®Google Scholar
• Higuchi, T., Takeuchi, A., Munesue, S., Yamamoto, N., Hayashi, K., Kimura, H., Miwa, S., Inatani, H., Shimozaki, S., Kato, T., Aoki, Y., Abe, K., Taniguchi, Y., Aiba, H., Murakami, H., Harashima, A., Yamamoto, Y., & Tsuchiya, H. (2018). Anti-tumor effects of a nonsteroidal anti-inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator-activated receptor gamma and suppressing matrix metalloproteinase-2 expression. Cancer Medicine, 7(5), 1944–1954. doi:10.1002/cam4.1438
   PubMed Web of Science ®Google Scholar
• Hong, O.-Y., Youn, H. J., Jang, H.-Y., Jung, S. H., Noh, E.-M., Chae, H. S., Jeong, Y.-J., Kim, W., Kim, C.-H., & Kim, J.-S. (2018). Troglitazone inhibits matrix metalloproteinase-9 expression and invasion of breast cancer cell through a peroxisome proliferator-activated receptor gamma-dependent mechanism. Journal of Breast Cancer, 21(1), 28–36. doi:10.4048/jbc.2018.21.1.28
   PubMed Web of Science ®Google Scholar
• Hossain, M. U., Khan, M. A., Rakib-Uz-Zaman, S. M., Ali, M. T., Islam, M. S., Keya, C. A., & Salimullah, M. (2016). Treating diabetes mellitus: Pharmacophore based designing of potential drugs from Gymnema sylvestre against insulin receptor protein. BioMed Research International, 2016, 3187647. doi:10.1155/2016/3187647
   PubMed Web of Science ®Google Scholar
• Jia, W.-Q., Jing, Z., Liu, X., Feng, X.-Y., Liu, Y.-Y., Wang, S.-Q., Xu, W.-R., Liu, J.-W., & Cheng, X.-C. (2018). Virtual identification of novel PPARalpha/gamma dual agonists by scaffold hopping of saroglitazar. Journal of Biomolecular Structure & Dynamics, 36(13), 3496–3512. doi:10.1080/07391102.2017.1392363
   PubMed Web of Science ®Google Scholar
• Joung, K. H., Ju, S. H., Kim, J. M., Choung, S., Lee, J. M., Park, K. S., Kim, H. J., & Ku, B. J. (2018). Clinical Implications of using post-challenge plasma glucose levels for early diagnosis of type 2 diabetes mellitus in older individuals. Diabetes & Metabolism Journal, 42(2), 147–154. doi:10.4093/dmj.2018.42.2.147
   PubMed Web of Science ®Google Scholar
• Julin, J., Napari, I., & Vehkamaki, H. (2007). Comparative study on methodology in molecular dynamics simulation of nucleation. The Journal of Chemical Physics, 126(22), 224517. doi:10.1063/1.2740269
   PubMed Web of Science ®Google Scholar
• Kalathiya, U., Padariya, M., & Baginski, M. (2016). Identification of 1H-indene-(1,3,5,6)-tetrol derivatives as potent pancreatic lipase inhibitors using molecular docking and molecular dynamics approach. Biotechnology and Applied Biochemistry, 63(6), 765–778. doi:10.1002/bab.1432
   PubMed Web of Science ®Google Scholar
• Katari, S. K., Natarajan, P., Swargam, S., Kanipakam, H., Pasala, C., & Umamaheswari, A. (2016). Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations. Journal of Receptor and Signal Transduction Research, 36(6), 558–571. doi:10.3109/10799893.2016.1141955
   PubMed Web of Science ®Google Scholar
• Kaul, U., Parmar, D., Manjunath, K., Shah, M., Parmar, K., Patil, K. P., & Jaiswal, A. (2019). New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: Integrated analysis of the real world evidence. Cardiovascular Diabetology, 18(1), 80. doi:10.1186/s12933-019-0884-3
   PubMedGoogle Scholar
• Kirubakaran, P., Kothapalli, R., Singh Kh, D., Nagamani, S., Arjunan, S., & Muthusamy, K. (2011). In silico studies on marine actinomycetes as potential inhibitors for Glioblastoma multiforme. Bioinformation, 6(3), 100–106. doi:10.6026/97320630006100
   PubMedGoogle Scholar
• Kumar, S., Saini, V., Maurya, I. K., Sindhu, J., Kumari, M., Kataria, R., & Kumar, V. (2018). Design, synthesis, DFT, docking studies and ADME prediction of some new coumarinyl linked pyrazolylthiazoles: Potential standalone or adjuvant antimicrobial agents. PLoS One, 13(4), e0196016. doi:10.1371/journal.pone.0196016
   PubMed Web of Science ®Google Scholar
• Lamichane, S., Dahal Lamichane, B., & Kwon, S. M. (2018). Pivotal roles of peroxisome proliferator-activated receptors (PPARs) and their signal cascade for cellular and whole-body energy homeostasis. International Journal of Molecular Sciences., 19(4), 949.
   Web of Science ®Google Scholar
• Lee, Y. H., Kim, J. H., Kim, S. R., Jin, H. Y., Rhee, E. J., Cho, Y. M., & Lee, B. W. (2017). Lobeglitazone, a novel thiazolidinedione, improves non-alcoholic fatty liver disease in type 2 diabetes: Its efficacy and predictive factors related to responsiveness. Journal of Korean Medical Science, 32(1), 60–69. doi:10.3346/jkms.2017.32.1.60
   PubMed Web of Science ®Google Scholar
• Li, R., Du, Y., Gao, Z., & Shen, J. (2018). Molecular modeling studies on carbazole carboxamide based BTK inhibitors using docking and structure-based 3D-QSAR. International Journal of Molecular Sciences., 19(4), 1244.
   Web of Science ®Google Scholar
• Liu, X., Jing, Z., Jia, W.-Q., Wang, S.-Q., Ma, Y., Xu, W.-R., Liu, J.-W., & Cheng, X.-C. (2018). Identification of novel PPARalpha/gamma dual agonists by virtual screening, ADMET prediction and molecular dynamics simulations. Journal of Biomolecular Structure & Dynamics, 36(11), 2988–3002. doi:10.1080/07391102.2017.1373706
   PubMed Web of Science ®Google Scholar
• Mahmoodian, R., Salimian, M., Hamidpour, M., Khadem-Maboudi, A. A., & Gharehbaghian, A. (2019). The effect of mild agonist stimulation on the platelet reactivity in patients with type 2 diabetes mellitus. BMC Endocrine Disorders, 19(1), 62.
   PubMedGoogle Scholar
• Mondal, S., Mandal, S. M., Mondal, T. K., & Sinha, C. (2015). Structural characterization of new Schiff bases of sulfamethoxazole and sulfathiazole, their antibacterial activity and docking computation with DHPS protein structure. Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy, 150, 268–279.
   PubMed Web of Science ®Google Scholar
• Narayanaswamy, R., Isha, A., Wai, L. K., & Ismail, I. S. (2016). Molecular docking analysis of selected Clinacanthus nutans constituents as xanthine oxidase, nitric oxide synthase, human neutrophil elastase, matrix metalloproteinase 2, matrix metalloproteinase 9 and squalene synthase inhibitors. Pharmacognosy Magazine, 12(Suppl 1), S21–S26.
   PubMedGoogle Scholar
• Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., & Milburn, M. V. (1998). Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature, 395(6698), 137–143. doi:10.1038/25931
   PubMed Web of Science ®Google Scholar
• Norinder, U., & Bergstrom, C. A. (2006). Prediction of ADMET properties. ChemMedChem., 1(9), 920–937. doi:10.1002/cmdc.200600155
   PubMed Web of Science ®Google Scholar
• Patronov, A., Dimitrov, I., Flower, D. R., & Doytchinova, I. (2012). Peptide binding to HLA-DP proteins at pH 5.0 and pH 7.0: A quantitative molecular docking study. BMC Structural Biology, 12, 20. doi:10.1186/1472-6807-12-20
   PubMed Web of Science ®Google Scholar
• Pradhan, D., Priyadarshini, V., Munikumar, M., Swargam, S., Umamaheswari, A., & Bitla, A. (2014). Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: Homology modeling, docking, and molecular dynamics study. Journal of Biomolecular Structure & Dynamics, 32(2), 171–185. doi:10.1080/07391102.2012.758056
   PubMed Web of Science ®Google Scholar
• Puratchikody, A., Sriram, D., Umamaheswari, A., & Irfan, N. (2016). 3-D structural interactions and quantitative structural toxicity studies of tyrosine derivatives intended for safe potent inflammation treatment. Chemistry Central Journal, 10, 24.
   PubMed Web of Science ®Google Scholar
• Rajamanikandan, S., Jeyakanthan, J., & Srinivasan, P. (2017). Molecular docking, molecular dynamics simulations, computational screening to design quorum sensing inhibitors targeting LuxP of vibrio harveyi and its biological evaluation. Applied Biochemistry and Biotechnology, 181(1), 192–218. doi:10.1007/s12010-016-2207-4
   PubMed Web of Science ®Google Scholar
• Rajamanikandan, S., & Srinivasan, P. (2016). Pharmacophore modeling and structure-based virtual screening to identify potent inhibitors targeting LuxP of Vibrio harveyi. Journal of Receptor and Signal Transduction Research, 36(6), 617–632. doi:10.3109/10799893.2016.1155063
   PubMed Web of Science ®Google Scholar
• Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. doi:10.1007/s10822-013-9644-8
   PubMed Web of Science ®Google Scholar
• Shan, Y., Kim, E. T., Eastwood, M. P., Dror, R. O., Seeliger, M. A., & Shaw, D. E. (2011). How does a drug molecule find its target binding site? Journal of the American Chemical Society, 133(24), 9181–9183. doi:10.1021/ja202726y
   PubMed Web of Science ®Google Scholar
• Shi, R., Zhao, L., & Qi, Y. (2018). The effect of fenofibrate on early retinal nerve fiber layer loss in type 2 diabetic patients: A case-control study. BMC Ophthalmology, 18(1), 100. doi:10.1186/s12886-018-0769-3
   PubMedGoogle Scholar
• Singh, K. D., & Muthusamy, K. (2013). Molecular modeling, quantum polarized ligand docking and structure-based 3D-QSAR analysis of the imidazole series as dual AT(1) and ET(A) receptor antagonists. Acta Pharmacologica Sinica, 34(12), 1592–1606. doi:10.1038/aps.2013.129
   PubMed Web of Science ®Google Scholar
• Sosale, A., Saboo, B., & Sosale, B. (2015). Saroglitazar for the treatment of hypertrig-lyceridemia in patients with type 2 diabetes: Current evidence. Diabetes, Metabolic Syndrome and Obesity : targets and Therapy, 8, 189–196.
   PubMed Web of Science ®Google Scholar
• Wang, X. J., Zhang, J., Wang, S. Q., Xu, W. R., Cheng, X. C., & Wang, R. L. (2014). Identification of novel multitargeted PPARalpha/gamma/delta pan agonists by core hopping of rosiglitazone. Drug Design, Development and Therapy, 8, 2255–2262.
   PubMed Web of Science ®Google Scholar
• Xu, S., & Xu, X. (2018). Research advances in the correlation between peroxisome proliferator-activated receptor-gamma and digestive cancers. PPAR Research, 2018, 5289859. doi:10.1155/2018/5289859
   PubMed Web of Science ®Google Scholar
• Yadava, U., Gupta, H., & Roychoudhury, M. (2015). Stabilization of microtubules by taxane diterpenoids: Insight from docking and MD simulations. Journal of Biological Physics, 41(2), 117–133. doi:10.1007/s10867-014-9369-5
   PubMed Web of Science ®Google Scholar
• Yadava, U., Shukla, B. K., Roychoudhury, M., & Kumar, D. (2015). Pyrazolo[3,4-d]pyrimidines as novel inhibitors of O-acetyl-L-serine sulfhydrylase of Entamoeba histolytica: An in silico study. Journal of Molecular Modeling, 21(4), 96. doi:10.1007/s00894-015-2631-3
   PubMed Web of Science ®Google Scholar
• Yokoyama, M., Fujisaki, S., Shirakura, M., Watanabe, S., Odagiri, T., Ito, K., & Sato, H. (2017). Molecular dynamics simulation of the influenza A(H3N2) hemagglutinin trimer reveals the structural basis for adaptive evolution of the recent epidemic clade 3C.2a. Frontiers in Microbiology, 8, 584.
   PubMed Web of Science ®Google Scholar
• Yun, S. H., Han, S. H., & Park, J. I. (2018). Peroxisome proliferator-activated receptor gamma and PGC-1alpha in cancer: Dual actions as tumor promoter and suppressor. PPAR Research, 2018, 6727421. doi:10.1155/2018/6727421
   PubMed Web of Science ®Google Scholar
• Zhang, D., & Lazim, R. (2017). Application of conventional molecular dynamics simulation in evaluating the stability of apomyoglobin in urea solution. Scientific Reports, 7, 44651. doi:10.1038/srep44651
   PubMed Web of Science ®Google Scholar